Trials / Completed
CompletedNCT00998257
Regulatory Post Marketing Surveillance Study on YAZ
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 770 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EE20/DRSP (YAZ, BAY86-5300) | Patients under daily life treatment with YAZ according to local drug information. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2009-10-20
- Last updated
- 2015-01-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00998257. Inclusion in this directory is not an endorsement.